{"transactions":[{"id":1993407,"issuer":{"id":114543,"kind":"organization","name":"ObsEva SA","symbol":"OBSV"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-24T16:50:38.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":250000,"derivative":{"exercise_price":0.1686,"expiration_date":"2033-02-22","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-012759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000120919123012759/doc4.xml","form_type":"4"}},{"id":2611592,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2021-08-06T19:01:07.000Z","date":"2021-07-31","kind":"grant","acquired":true,"shares":803,"price":7.7095,"value":6190.7285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2021 through July 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2021."}],"balance_after":17721,"source":{"system":"sec-edgar","filing":"0001104659-21-101662","document":"tm2124283-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000110465921101662/tm2124283-2_4seq1.xml","form_type":"4"}},{"id":2882087,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-03T19:00:31.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":24664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date."}],"balance_after":24664,"derivative":{"underlying":"Common Stock, par value $0.0001","underlying_shares":24664},"source":{"system":"sec-edgar","filing":"0000899243-21-004755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924321004755/doc4.xml","form_type":"4"}},{"id":2882086,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (option to buy)","published_at":"2021-02-03T19:00:31.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2022 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":16.71,"expiration_date":"2031-02-01","underlying":"Common Stock, par value $0.0001","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-21-004755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924321004755/doc4.xml","form_type":"4"}},{"id":2882085,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2021-02-03T19:00:31.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":937,"price":12.14,"value":11375.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2020 through January 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2021."}],"balance_after":16918,"source":{"system":"sec-edgar","filing":"0000899243-21-004755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924321004755/doc4.xml","form_type":"4"}},{"id":3069805,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-08-04T18:47:15.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":7920,"price":1.46,"value":11563.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020."}],"balance_after":15981,"source":{"system":"sec-edgar","filing":"0000899243-20-021212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924320021212/doc4.xml","form_type":"4"}},{"id":3292048,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-02-04T20:34:39.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":8061,"price":1.46,"value":11769.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from August 1, 2019 through January 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2020."}],"balance_after":8061,"source":{"system":"sec-edgar","filing":"0000899243-20-003006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924320003006/doc4.xml","form_type":"4"}},{"id":3323514,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (option to buy)","published_at":"2020-01-03T17:00:49.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":61400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on January 2, 2021 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 2, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":61400,"derivative":{"exercise_price":1.9213,"expiration_date":"2030-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":61400},"source":{"system":"sec-edgar","filing":"0000899243-20-000275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924320000275/doc4.xml","form_type":"4"}},{"id":3492898,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-06-12T16:50:05.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on June 1, 2020 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following June 1, 2020, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.34,"expiration_date":"2029-06-10","underlying":"Common Stock, par value $0.0001","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-016650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000089924319016650/doc4.xml","form_type":"4"}},{"id":3704357,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":116476,"kind":"person","name":"Brown William Michael","position":1,"cik":"0001742241","reported_name":"Brown William Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting Chief Financial Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T17:31:34.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable upon the filing of the Issuer's annual statement on Form 10-K with respect to the fiscal year ended December 31, 2018, generally subject to the reporting person's continued service through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.6,"expiration_date":"2024-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001012975-19-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742241/000101297519000043/edgar.xml","form_type":"4"}}]}